Sera Prognostics, Inc. (SERA)
NASDAQ: SERA · Real-Time Price · USD
3.660
+0.140 (3.98%)
At close: Jan 16, 2026, 4:00 PM EST
3.660
0.00 (0.00%)
After-hours: Jan 16, 2026, 5:16 PM EST
Sera Prognostics Market Cap
Sera Prognostics has a market cap or net worth of $141.26 million as of January 16, 2026. Its market cap has decreased by -49.85% in one year.
Market Cap
141.26M
Enterprise Value
41.32M
1-Year Change
-49.85%
Ranking
Category
Stock Price
$3.66
Market Cap Chart
Since the IPO on July 15, 2021, Sera Prognostics's market cap has decreased from $488.14M to $141.26M, a decrease of -71.06%. That is a compound annual growth rate of -24.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 15, 2026 | 135.85M | 19.32% |
| Dec 31, 2025 | 113.85M | -58.58% |
| Dec 31, 2024 | 274.91M | 46.70% |
| Dec 29, 2023 | 187.39M | 379.49% |
| Dec 30, 2022 | 39.08M | -81.47% |
| Dec 31, 2021 | 210.90M | -56.79% |
| Jul 15, 2021 | 488.14M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 961.00B |
| Johnson & Johnson | 526.55B |
| AbbVie | 392.16B |
| UnitedHealth Group | 303.42B |
| AstraZeneca | 299.25B |
| Novartis AG | 278.73B |
| Merck & Co. | 275.53B |
| Novo Nordisk | 262.20B |